Christopher R. Noyes advises pharmaceutical and biotechnology companies on complex intellectual property matters. He has successfully litigated life sciences cases in district courts across the United States, including taking numerous cases to trial in popular venues for Hatch-Waxman litigation, such as the District of New Jersey and District of Delaware.
With more than 14 years of experience, he has helped his clients to protect their intellectual property and defend their business around the globe. During his career, Mr. Noyes has litigated cases involving small molecules, biologics, vaccines, pharmaceutical formulations, DNA diagnostic technology and more. He also has experience litigating intellectual property disputes for a variety of high technology clients, including those in the semiconductor and solar industries.
Mr. Noyes has served as a faculty member for the Massachusetts Continuing Legal Education Pretrial Litigation Basics Seminar and as an advisor to students participating in the Harvard Law School mock trial program. Mr. Noyes is a member of the American Bar Association and the New York State Bar Association.
- Secured a significant victory at the Federal Circuit for Braintree Laboratories, Inc. when the appeals court reversed a district court’s grant of summary judgment of noninfringement for Breckenridge Pharmaceutical and remanded with instructions to enter judgment in Braintree’s favor. This Hatch-Waxman matter involved a patent owned by Braintree pertaining to its product SUPREP, a highly successful product designed to cleanse the colon safely before a colonoscopy.
- Achieved a significant victory on behalf of our clients, multiple medical device and diagnostics companies, when the District of Delaware granted summary judgment invalidating the key patent asserted against our clients. The judge ultimately entered a final judgment as to that patent, stayed the remainder of the claims and closed the cases.
- Obtained a favorable result for our client, a large pharmaceutical company, resolving global litigation with a rival pharmaceutical company related to their competing vaccines. A settlement resolved proceedings in Australia, Ireland, Italy, the United Kingdom, the United States, the European Patent Office and the USPTO. Mr. Noyes was the lead New York partner for the litigation.
- Acted as second chair and conducted all cross examinations of the defense experts in a remand trial on infringement and obtained a victory for the client when the judge found that the proposed generic product would infringe five asserted claims of our client’s patent if marketed and sold. Representation began in 2013 with trial where Mr. Noyes was second chair and was primarily responsible for presenting the case on validity. The Court found that the claims of the patent at issue are invalid for obviousness, anticipation or indefiniteness.
- JD, University of Michigan Law School, 2002
- BA, Political Science, University of Vermont, 1999
ADMISSIONS : New York, Massachusetts
- The Hon. Patrick Leahy, Ranking Member, Senate Judiciary Committee, 2000
- The Hon. Marilyn S. Skoglund, Vermont Supreme Court, 2002 – 2003
Rate : $$$